logo

IQV

IQVIA·NYSE
--
--(--)
--
--(--)

IQV fundamentals

IQVIA (IQV) released its earnings on Feb 5, 2026: revenue was 4.36B (YoY +10.16%), beat estimates; EPS was 3.42 (YoY +9.62%), beat estimates.
Revenue / YoY
4.36B
+10.16%
EPS / YoY
3.42
+9.62%
Report date
Feb 5, 2026
IQV Earnings Call Summary for Q4,2025
  • Strong 2025 Performance: 6% revenue growth, 7% EPS growth, $2.1B free cash flow. Q4 revenue $4.36B (+10.3% YoY).
  • AI Leadership: 150+ AI agents deployed, AWS #1 generative AI ranking, AI-driven commercial wins with top pharma.
  • Clinical Momentum: Q4 bookings $2.7B, backlog $32.7B, R&D pipeline +10% YoY.
  • 2026 Guidance: Revenue $17.15-17.35B, EPS $12.55-12.85, flat EBITDA margin with moderating pass-throughs.
  • Defensible Position: Proprietary health data scale, domain expertise, and regulatory compliance protect against AI disruption.
EPS
Revenue

Revenue & Expenses

IQV has released its 2025 Q4 earnings report, with revenue of 4.36B, reflecting a YoY change of 10.26%, and net profit of 514.00M, showing a YoY change of 17.62%. The Sankey diagram below clearly presents IQV's revenue sources and cost distribution.

Key Indicators

IQVIA (IQV) key financial stats and ratios, covering profitability, financial health, and leverage.
IQVIA (IQV)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
IQVIA (IQV)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
IQVIA (IQV)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does IQVIA (IQV) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track IQVIA (IQV) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield